Nissan Motor Becomes Activist Investor Effissimo's Next Prestigious Japanese Target
Shares in Nissan Motor soared on news of the stake, rising more than 20% at one point on Tuesday. They rose again on Friday when Japanese magazine Diamond reported that another activist investor, ...
Business Insider1d
Biogen price target raised to $300 from $294 at Baird
Baird raised the firm’s price target on Biogen (BIIB) to $300 from $294 and keeps an Outperform rating on the shares. The firm said Biogen partner Eisai’s request for the EMA’s CHMP to reexamine the ...
Eisai receives positive CHMP opinion for Lecanemab in early Alzheimer’s disease
Eisai (ESAIY) and Biogen (BIIB) announced that a positive opinion has been received from the Committee for Medicinal Products for Human Use of ...
5 Healthcare Stocks to Buy in a Beaten-Up Sector
It has been a shaky time for healthcare stocks, but that only presents a buying opportunity. The Health Care Select Sector ...
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
CHMP issues positive recommendation for approval of lecanemab in the EU
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announces that EMA's Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation regarding BioArctic's partner Eisai ...
Eisai: Still Relatively Modest Market-Implied Expectations For Leqembi
Analysis of Leqembi's commercial potential and market outlook, with a focus on growth projections and investment ...
This Artificial Intelligence (AI) Stock Is Down 30% From Its 52-Week Highs: Is It Worth Buying Right Now?
Reliance on a single customer for a huge chunk of revenue is weighing on this company, but that could turn into an advantage ...